A groundbreaking study led by the Icahn School of Medicine at Mount Sinai and recently published in Nature Medicine reveals that the genetic factors contributing to autism are remarkably consistent across people of diverse ancestries. This research, incorporating one of the most comprehensive genomic analyses conducted on Latin American populations, adds substantial clarity to the universal nature of autism’s genetic architecture. It breaks new ground in understanding how rare genetic variants implicated in autism risk do not significantly differ between ancestral groups, thereby highlighting the pressing need to broaden genetic studies beyond traditionally Eurocentric cohorts.
Autism spectrum disorder, a complex neurodevelopmental condition, has long been linked to rare genetic mutations that carry major risk implications. Yet, the vast majority of these genetic discoveries have emerged from studies primarily involving individuals of European descent, creating a significant research gap regarding autism’s genetic basis in other populations. This skew has saddled non-European individuals with less informative genetic test results, leaving many families without clear answers. The recent study addresses this disparity by bringing to light the shared genetic underpinnings of autism among Latin American populations, which are genetically diverse due to a history of Indigenous American, European, and African ancestries.
The investigation analyzed whole exome and whole genome sequencing data from over 15,000 Latin American individuals, which notably included approximately 4,700 diagnosed with autism. This cohort represents one of the largest and most varied ancestries ever assessed in autism genetics research. By examining more than 18,000 genes, the researchers focused on the enrichment of rare, deleterious coding variants—mutations that disrupt the function of proteins and are thus highly relevant to both clinical diagnostics and understanding disease mechanisms.
Findings from the study accentuate that rare damaging mutations in genes that remain evolutionarily conserved are disproportionately present in individuals diagnosed with autism. These genes have resisted extensive evolutionary changes across species over millions of years, indicating their pivotal biological functions. The identification of 35 genes with significant associations to autism in the Latin American cohort mirrors many genes previously implicated in European-ancestry studies, suggesting a core set of autism risk genes that transcend ancestral boundaries.
These discoveries also extend support to several recently identified “emerging” autism risk genes, which had lacked robust validation until now. The convergence of genetic risk factors across ancestries strengthens the hypothesis that the biological mechanisms driving autism are largely universal rather than population-specific. This insight has profound implications for research equity, urging the expansion of genetic databases to incorporate underrepresented populations to achieve more accurate and inclusive genetic diagnoses.
An integral part of the study also scrutinized the gene conservation metrics commonly used in clinical genetics to prioritize genes for their potential role in neurodevelopmental disorders. Historically, these metrics have been generated from datasets predominantly comprising individuals of European origin, possibly biasing evolutionary conservation estimates. The researchers found that while these metrics might generally overestimate conservation due to limited ancestral diversity, their accuracy remains reliable for highly conserved genes most pertinent to disorders like autism.
The continual inclusion of diverse genetic data from broad populations promises to refine these conservation metrics further. Improving the precision with which less conserved genes are evaluated will ultimately enhance clinical genetic testing accuracy. This progress is essential for advancing personalized medicine approaches, ensuring that people from all backgrounds receive equitable and precise diagnostic evaluations and treatment options.
Dr. Joseph D. Buxbaum, the study’s senior author and Director of the Seaver Autism Center for Research and Treatment at Mount Sinai, emphasized, “Our results indicate that the core genetic architecture of autism is shared across ancestries.” This affirmation reinforces the universality of the biological foundations of autism and calls for a more diverse and inclusive framework in genetic research. A more representative genomic landscape in science will bridge current health disparities and propel precision medicine forward.
The study’s methodological rigor combined observational analyses of both exome and genome sequencing data—two complementary genomic approaches that catalogue protein-coding regions and the entire genomic sequence, respectively. This dual approach allowed the researchers to capture rare deleterious mutations that could be obscured in less comprehensive studies or in those focusing only on a single population. Furthermore, the robust sample size and population diversity facilitated enhanced statistical power to detect gene-disease associations with greater confidence.
In the broader context, this research aligns with increasing evidence from studies of complex disorders, where both common and rare genetic variants appear to show substantial consistency across global populations. Such consistency underscores the feasibility and importance of building universal genetic models that are not overly reliant on any one population’s genetic information. Broadening participation in genomic research is thus a crucial step toward equitable healthcare and better outcomes for autism and related neurodevelopmental conditions worldwide.
Mount Sinai’s role as a major academic health system shines through in the translational efforts behind this work, bridging the gap between genomic discovery and clinical application. Its emphasis on integrating cutting-edge genomic science with patient-centered care exemplifies the transformative potential of multidisciplinary research collaborations. Leveraging advanced bioinformatics, artificial intelligence, and diverse genetic datasets sets a new precedent for future studies in the field.
This study heralds a new chapter in autism research and genomics. Beyond its immediate scientific impact, it carries a powerful social message: that inclusivity in research not only promotes justice but also enhances the scientific robustness of findings that affect millions of lives. Continued efforts to include underrepresented populations in genetic research hold the promise of delivering more equitable diagnostics, therapies, and support for families across all ancestries affected by autism spectrum disorder.
Subject of Research: People
Article Title: Deleterious coding variation associated with autism is shared across ancestries
News Publication Date: 30-Mar-2026
Web References: https://www.mountsinai.org, https://www.nature.com/articles/s41591-026-04228-6
References: DOI: 10.1038/s41591-026-04228-6
Image Credits: Marina Natividad Avila, MSc
Keywords: Autism, Genomics, Genome sequencing, Genomic analysis, Exome sequencing
